The schemes focus primarily on cancer, rare diseases and severe chronic conditions, areas where treatment costs are high and often require expensive biological and originator drugs.
Data is the life-blood of physical AI. Collecting real-life data is expensive. Generative AI and diffusion to create ...
LONDON, UNITED KINGDOM, February 24, 2026 /EINPresswire.com/ -- In a video published on Business Reporter, Ante ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results